131 related articles for article (PubMed ID: 2097310)
21. Stability studies of topical carbonic anhydrase inhibitor 6-hydroxyethoxy-2-benzothiazole sulfonamide.
Chiang CH; Hsieh CH; Lu DW; Kao KD
J Pharm Sci; 1992 Mar; 81(3):299-302. PubMed ID: 1640372
[TBL] [Abstract][Full Text] [Related]
22. The preclinical pharmacology of dorzolamide hydrochloride, a topical carbonic anhydrase inhibitor.
Sugrue MF
J Ocul Pharmacol Ther; 1996; 12(3):363-76. PubMed ID: 8875343
[TBL] [Abstract][Full Text] [Related]
23. The effect of cyclooxygenase inhibition on the ocular hypotensive action of topical carbonic anhydrase inhibitors in rabbits.
Sugrue MF; O'Neill-Davis L
J Ocul Pharmacol; 1991; 7(3):201-11. PubMed ID: 1783853
[TBL] [Abstract][Full Text] [Related]
24. 6-amino-2-benzothiazole-sulfonamide. The effect of a topical carbonic anhydrase inhibitor on aqueous humor formation in the normal human eye.
Kalina PH; Shetlar DJ; Lewis RA; Kullerstrand LJ; Brubaker RF
Ophthalmology; 1988 Jun; 95(6):772-7. PubMed ID: 3211479
[TBL] [Abstract][Full Text] [Related]
25. Preclinical overview of brinzolamide.
DeSantis L
Surv Ophthalmol; 2000 Jan; 44 Suppl 2():S119-29. PubMed ID: 10665514
[TBL] [Abstract][Full Text] [Related]
26. Topical ocular hypotensive activity and ocular penetration of dichlorphenamide sodium in rabbits.
Lotti VJ; Schmitt CJ; Gautheron PD
Graefes Arch Clin Exp Ophthalmol; 1984; 222(1):13-9. PubMed ID: 6510719
[TBL] [Abstract][Full Text] [Related]
27. Carbonic anhydrase inhibitors: synthesis and topical intraocular pressure lowering effects of fluorine-containing inhibitors devoid of enhanced reactivity.
de Leval X; Ilies M; Casini A; Dogné JM; Scozzafava A; Masini E; Mincione F; Starnotti M; Supuran CT
J Med Chem; 2004 May; 47(11):2796-804. PubMed ID: 15139757
[TBL] [Abstract][Full Text] [Related]
28. Comparison of intraocular pressure lowering by topical and systemic carbonic anhydrase inhibitors in the rabbit.
Fanous MM; Challa P; Maren TH
J Ocul Pharmacol Ther; 1999 Feb; 15(1):51-7. PubMed ID: 10048347
[TBL] [Abstract][Full Text] [Related]
29. Ocular disposition of aminozolamide in the rabbit eye.
Putnam ML; Schoenwald RD; Duffel MW; Barfknecht CF; Segarra TM; Campbell DA
Invest Ophthalmol Vis Sci; 1987 Aug; 28(8):1373-82. PubMed ID: 3610554
[TBL] [Abstract][Full Text] [Related]
30. Topically active carbonic anhydrase inhibitors. 4. [(Hydroxyalkyl)sulfonyl]benzene and [(hydroxyalkyl)sulfonyl]thiophenesulfonamides.
Shepard KL; Graham SL; Hudcosky RJ; Michelson SR; Scholz TH; Schwam H; Smith AM; Sondey JM; Strohmaier KM; Smith RL
J Med Chem; 1991 Oct; 34(10):3098-105. PubMed ID: 1920359
[TBL] [Abstract][Full Text] [Related]
31. Carbonic anhydrase inhibitors: synthesis of water-soluble, topically effective intraocular pressure lowering aromatic/heterocyclic sulfonamides containing 8-quinoline-sulfonyl moieties: is the tail more important than the ring?
Borras J; Scozzafava A; Menabuoni L; Mincione F; Briganti F; Mincione G; Supuran CT
Bioorg Med Chem; 1999 Nov; 7(11):2397-406. PubMed ID: 10632049
[TBL] [Abstract][Full Text] [Related]
32. [Pharmacological profiles of the potent carbonic anhydrase inhibitor dorzolamide hydrochloride, a topical antiglaucoma agent].
Kobayashi M; Naito K
Nihon Yakurigaku Zasshi; 2000 Jun; 115(6):323-8. PubMed ID: 10948564
[TBL] [Abstract][Full Text] [Related]
33. Carbonic anhydrase inhibitors. Part 60(#). The topical intraocular pressure-lowering properties of metal complexes of a heterocyclic sulfonamide: influence of the metal ion upon biological activity.
Supuran CT; Scozzafava A; Mincione F; Menabuoni L; Briganti F; Mincione G; Jitianu M
Eur J Med Chem; 1999; 34(7-8):585-95. PubMed ID: 11278044
[TBL] [Abstract][Full Text] [Related]
34. Acetazolamide-like carbonic anhydrase inhibitors with topical ocular hypotensive activity.
Antonaroli S; Bianco A; Brufani M; Cellai L; Lo Baido G; Potier E; Bonomi L; Perfetti S; Fiaschi AI; Segre G
J Med Chem; 1992 Jul; 35(14):2697-703. PubMed ID: 1635066
[TBL] [Abstract][Full Text] [Related]
35. 2H-Thieno[3,2-e]- and [2,3-e]-1,2-thiazine-6-sulfonamide 1,1-dioxides as ocular hypotensive agents: synthesis, carbonic anhydrase inhibition and evaluation in the rabbit.
Chen HH; Gross S; Liao J; McLaughlin M; Dean T; Sly WS; May JA
Bioorg Med Chem; 2000 May; 8(5):957-75. PubMed ID: 10882008
[TBL] [Abstract][Full Text] [Related]
36. Ocular hypotensive effects of anti-glaucoma agents in mice.
Akaishi T; Odani-Kawabata N; Ishida N; Nakamura M
J Ocul Pharmacol Ther; 2009 Oct; 25(5):401-8. PubMed ID: 19857101
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of a topically administered carbonic anhydrase inhibitor (MK-927) in normotensive and glaucomatous beagles.
King TC; Gum GG; Gelatt KN
Am J Vet Res; 1991 Dec; 52(12):2067-70. PubMed ID: 1789524
[TBL] [Abstract][Full Text] [Related]
38. 3-substituted thieno[2,3-b][1,4]thiazine-6-sulfonamides. A novel class of topically active carbonic anhydrase inhibitors.
Hunt CA; Mallorga PJ; Michelson SR; Schwam H; Sondey JM; Smith RL; Sugrue MF; Shepard KL
J Med Chem; 1994 Jan; 37(2):240-7. PubMed ID: 8295211
[TBL] [Abstract][Full Text] [Related]
39. Chemical and pharmacological properties of MK-927, a sulfonamide carbonic anhydrase inhibitor that lowers intraocular pressure by the topical route.
Maren TH; Bar-Ilan A; Conroy CW; Brechue WF
Exp Eye Res; 1990 Jan; 50(1):27-36. PubMed ID: 2307193
[TBL] [Abstract][Full Text] [Related]
40. Topical carbonic anhydrase inhibitors: potential adjuvants to glaucoma therapy in the future.
Scott BT
Optom Vis Sci; 1994 May; 71(5):332-8. PubMed ID: 8065709
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
